Skip to main content
. 2012 Jun 15;13:103. doi: 10.1186/1471-2474-13-103

Table 3.

Sensitivity Analysis of Incidence Rates per 100,000 person-years (2004–2008)

 
Commercial and Medicare supplemental database
Medicaid database
  N Crude rate Age & Gender adjusted rate 95% CI for adjusted rate N Crude rate Age & Gender adjusted rate 95% CI for adjusted rate
Base case analysis (IIMs)
2,477
4.88
4.27
4.09-4.44
513
5.20
5.23
4.74-5.72
Dermatomyositis
902
1.78
1.52
1.42-1.63
170
1.72
1.70
1.42-1.97
Polymyositis
1,438
2.83
2.46
2.33-2.59
346
3.51
3.53
3.13-3.94
Interstitial myositis
401
0.79
0.73
0.66-0.81
75
0.76
0.78
0.58-0.97
Presence of muscle biopsy one year prior to or one year following index date
IIMs
738
1.45
1.25
1.16-1.35
102
1.03
1.05
0.83-1.27
Dermatomyositis
248
0.49
0.43
0.38-0.49
34
0.34
0.34
0.22-0.46
Polymyositis
574
1.13
0.96
0.88-1.04
88
0.89
0.91
0.70-1.11
Interstitial myositis
21
0.04
0.04
0.02-0.06
2
0.02
0.02
0.01-0.04
Presence of specialist visit on index date or in the year following
IIMs
535
1.05
0.91
0.82-0.99
64
0.65
0.63
0.46-0.79
Dermatomyositis
207
0.41
0.35
0.30-0.40
21
0.21
0.24
0.13-0.35
Polymyositis
374
0.74
0.63
0.56-0.70
49
0.50
0.46
0.32-0.59
Interstitial myositis
27
0.05
0.05
0.03-0.07
8
0.08
0.06
0.02-0.10
Presence of immunosuppressants and/or systemic corticosteroids one year following index date
IIMs
1,761
3.47
3.01
2.86-3.16
304
3.08
3.07
2.70-3.44
Dermatomyositis
725
1.43
1.24
1.14-1.33
103
1.04
1.02
0.80-1.23
Polymyositis
1,146
2.26
1.96
1.84-2.08
225
2.28
2.29
1.97-2.61
Interstitial myositis
133
0.26
0.23
0.19-0.27
32
0.32
0.31
0.20-0.43
Presence of any of the above (combined sensitivity criteria)
IIMs
1,917
3.78
3.29
3.13-3.44
347
3.52
3.50
3.10-3.89
Dermatomyositis
758
1.49
1.29
1.20-1.39
115
1.17
1.13
0.91-1.36
Polymyositis
1,250
2.46
2.14
2.01-2.26
257
2.61
2.62
2.28-2.97
Interstitial myositis 160 0.32 0.28 0.24-0.33 38 0.38 0.36 0.24-0.48